These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 16315297

  • 1. Recurrent hepatitis C after retransplantation: factors affecting graft and patient outcome.
    Carmiel-Haggai M, Fiel MI, Gaddipati HC, Abittan C, Hossain S, Roayaie S, Schwartz ME, Gondolesi G, Emre S, Schiano TD.
    Liver Transpl; 2005 Dec; 11(12):1567-73. PubMed ID: 16315297
    [Abstract] [Full Text] [Related]

  • 2. Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course.
    Gallegos-Orozco JF, Yosephy A, Noble B, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan D, Moss A, de Petris G, Williams JW, Rakela J, Vargas HE.
    Liver Transpl; 2009 Dec; 15(12):1872-81. PubMed ID: 19938138
    [Abstract] [Full Text] [Related]

  • 3. Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis.
    Berenguer M, Prieto M, Palau A, Rayón JM, Carrasco D, Juan FS, López-Labrador FX, Moreno R, Mir J, Berenguer J.
    Liver Transpl; 2003 Mar; 9(3):228-35. PubMed ID: 12619018
    [Abstract] [Full Text] [Related]

  • 4. Retransplantation of liver: primary graft nonfunction and hepatitis C virus are associated with worse outcome.
    Yoo HY, Maheshwari A, Thuluvath PJ.
    Liver Transpl; 2003 Sep; 9(9):897-904. PubMed ID: 12942450
    [Abstract] [Full Text] [Related]

  • 5. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, Holt C, Lewin KJ, Busuttil RW, Martin P.
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [Abstract] [Full Text] [Related]

  • 6. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation.
    McTaggart RA, Terrault NA, Vardanian AJ, Bostrom A, Feng S.
    Liver Transpl; 2004 Aug; 10(8):975-85. PubMed ID: 15390322
    [Abstract] [Full Text] [Related]

  • 7. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M, Fernandez JR, Suarez MJ, Gastaca M, Bustamante J, Pijoan JI, Montejo M, Valdivieso A, Ruiz P, Gonzalez J, Ortiz de Urbina J.
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [Abstract] [Full Text] [Related]

  • 8. Retransplantation for recurrent hepatitis C in the MELD era: maximizing utility.
    Burton JR, Sonnenberg A, Rosen HR.
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S59-64. PubMed ID: 15382221
    [Abstract] [Full Text] [Related]

  • 9. Risk factors in liver retransplantation: a single-center experience.
    Crivellin C, De Martin E, Germani G, Gambato M, Senzolo M, Russo FP, Vitale A, Zanus G, Cillo U, Burra P.
    Transplant Proc; 2011 May; 43(4):1110-3. PubMed ID: 21620065
    [Abstract] [Full Text] [Related]

  • 10. Hepatitis C recurrence is not associated with allograft steatosis within the first year after liver transplantation.
    Machicao VI, Krishna M, Bonatti H, Aqel BA, Nguyen JH, Weigand SD, Rosser BG, Hughes C, Dickson RC.
    Liver Transpl; 2004 May; 10(5):599-606. PubMed ID: 15108251
    [Abstract] [Full Text] [Related]

  • 11. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P, Senzolo M, Masier A, Prestele H, Jones R, Samuel D, Villamil F.
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [Abstract] [Full Text] [Related]

  • 12. A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation.
    Yilmaz N, Shiffman ML, Stravitz RT, Sterling RK, Luketic VA, Sanyal AJ, Mills AS, Contos MJ, Coterell A, Maluf D, Posner MP, Fisher RA.
    Liver Transpl; 2007 Jul; 13(7):975-83. PubMed ID: 17600360
    [Abstract] [Full Text] [Related]

  • 13. Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection.
    Neff GW, O'Brien CB, Nery J, Shire NJ, Nishida S, delaGarza J, Montalbano M, Safdar K, Ruiz P, Rideman E, Gascon JA, Tzakis AG, Madariaga J, Rudich SM.
    Liver Transpl; 2004 Dec; 10(12):1497-503. PubMed ID: 15558835
    [Abstract] [Full Text] [Related]

  • 14. Liver retransplantation of patients with hepatitis C infection is associated with acceptable patient and graft survival.
    Ghabril M, Dickson RC, Machicao VI, Aranda-Michel J, Keaveny A, Rosser B, Bonatti H, Krishna M, Yataco M, Satyanarayana R, Harnois D, Hewitt W, Willingham DD, Grewal H, Hughes CB, Nguyen J.
    Liver Transpl; 2007 Dec; 13(12):1717-27. PubMed ID: 18044750
    [Abstract] [Full Text] [Related]

  • 15. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.
    Yosry A, Esmat G, El-Serafy M, Omar A, Doss W, Said M, Abdel-Bary A, Hosny A, Marawan I, El-Malt O, Kamel RR, Hatata Y, Ghali A, Sabri H, Kamel S, El-Gbaly H, Tanaka K.
    Transplant Proc; 2008 Jun; 40(5):1481-4. PubMed ID: 18589133
    [Abstract] [Full Text] [Related]

  • 16. Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation.
    Ercolani G, Grazi GL, Ravaioli M, Del Gaudio M, Cescon M, Varotti G, Ramacciato G, Vetrone G, Zanello M, Pinna AD.
    Liver Transpl; 2006 Jul; 12(7):1104-11. PubMed ID: 16710855
    [Abstract] [Full Text] [Related]

  • 17. Prognostic factors for hepatitis C recurrence in patients undergoing orthotopic liver transplantation.
    Sánchez-Bueno F, Ortiz ML, Bermejo J, Miras M, Pons JA, Ramírez P, Robles R, Parrilla P.
    Transpl Immunol; 2006 Dec; 17(1):47-50. PubMed ID: 17157215
    [Abstract] [Full Text] [Related]

  • 18. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.
    Belli LS, Burroughs AK, Burra P, Alberti AB, Samonakis D, Cammà C, De Carlis L, Minola E, Quaglia A, Zavaglia C, Vangeli M, Patch D, Dhillon A, Cillo U, Guido M, Fagiuoli S, Giacomoni A, Slim OA, Airoldi A, Boninsegna S, Davidson BR, Rolles K, Pinzello G.
    Liver Transpl; 2007 May; 13(5):733-40. PubMed ID: 17370330
    [Abstract] [Full Text] [Related]

  • 19. HCV histological recurrence and survival following liver transplantation in patients with and without hepatocellular carcinoma.
    De Martin E, Senzolo M, Boninsegna S, Guido M, Masier A, Germani G, Tomat S, Brolese A, Neri D, Cillo U, Gambato M, Russo FP, Farinati F, Burra P.
    Transplant Proc; 2008 May; 40(6):1974-5. PubMed ID: 18675104
    [Abstract] [Full Text] [Related]

  • 20. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
    Rayhill SC, Wu YM, Katz DA, Voigt MD, Labrecque DR, Kirby PA, Mitros FA, Kalil RS, Miller RA, Stolpen AH, Schmidt WN.
    Transplantation; 2007 Aug 15; 84(3):331-9. PubMed ID: 17700157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.